Working to identify the root cause of multiple neurologic, psychiatric, and behavioral disorders.
Moleculera Biosciences to advance first-of-its-kind biomarker panel for Alzheimer’s through alliance with Lunai Bioworks
Read
Moleculera Forms Strategic Collaboration with Quest Diagnostics
Moleculera Labs, Inc., Awarded $500,000 Grant Funding to Develop Predictive Treatment Algorithm
Antineuronal antibody testing that can assist clinicians in identifying whether neuropsychiatric symptoms may be due to an underlying autoimmune response.
Infections can induce an autoimmune attack on the brain, leading to the onset of neurologic and/or psychiatric symptoms.
High complexity metabolic testing, based on over two decades of research and utilized by more than 2,500 clinicians worldwide.
An abnormal immune response, often triggered by an infection, can cause various neurologic and psychiatric symptoms.
This content is password protected. To view it please enter your password below:
Password:
